Aetiology of systemic inflammation and its link with prognosis in gastro-oesophageal cancer
dc.contributor.author
Deans, Derek Andrew Christopher
en
dc.date.accessioned
2018-05-22T12:38:17Z
dc.date.available
2018-05-22T12:38:17Z
dc.date.issued
2008
dc.description.abstract
INTRODUCTION:
As the incidence of gastro-oesophageal cancer continues to increase accurate staging
remains challenging and the general outlook for these patients is poor. As well as improving
prognostic accuracy, investigation of systemic inflammation and cachexia in these patients
may enable the identification of much needed novel therapeutic targets.
en
dc.description.abstract
AIMS:
The aims of this thesis were to describe the genesis, mediators and clinical sequelae of
systemic inflammation in patients with gastro -oesophageal cancer. The usefulness of
systemic inflammation as a prognostic indicator and the role of cachexia as a factor in the
adverse prognosis associated with systemic inflammation were expanded in detail. The key
hypothesis being that tumour cells produce mediators (eg cytokines), which can either directly
or indirectly (via systemic inflammation) induce a catabolic state in the peripheral tissues of
the host. Such wasting may be one of the mechanisms linking systemic inflammation with
adverse prognosis in patients with cancer.
en
dc.description.abstract
MATERIALS & METHODS:
A consecutive series of 220 patients with gastric or oesophageal cancer were studied. Data
were collected prospectively and a nutritional assessment and performance status were
determined for each patient and survival duration was recorded. Samples of blood, urine and
tumour tissue were collected for determination of cytokine and acute phase protein
concentrations. The expression of other potential tumour -derived mediators, parathyroid
hormone -related peptide (PTHrP) and proteolysis- inducing factor (PIF), were also studied.
en
dc.description.abstract
RESULTS:
Systemic inflammation (CRP >10 mg /I) was present in 43% of patients with gastrooesophageal
cancer. Serum acute phase protein concentrations (especially CRP), but not
serum cytokine concentrations, were robust measures of systemic inflammatory activity.
However, concentrations of pro -inflammatory cytokines within tumour tissue were significantly
elevated and were linked with markers of systemic inflammation. IL-18 in particular was over - expressed in tumour tissue and may be a key determinant of systemic inflammation in
patients with gastro -oesophageal malignancy. A chronic inflammatory cell infiltrate into the
tumour tissue was present in 75% of tumours and was also linked with markers of systemic
inflammation. Tumour cells or host immune cells or a combination of the two may be the main
source of these mediators. The presence of systemic inflammation was also influenced by
host cytokine genotype. Other potential tumour -derived mediators, such as PIF and PTHrP,
may also play a (minor) role in the generation of systemic inflammation. These factors may
also have additional effects on the host, such as potentiating weight loss. CRP concentrations
were identified as the best marker of prognosis and the magnitude of serum CRP
concentrations were negatively linked with survival duration.
en
dc.description.abstract
83% of patients had lost weight at the time of diagnosis and within 3 months this had
increased to 92 %. Increasing weight loss was positively associated with serum markers of
systemic inflammation. Weight loss among patients with gastro -oesophageal cancer was not
accounted for entirely by reduced food intake or mechanical obstruction secondary to the
tumour. Alternatively, the presence of systemic inflammation contributed to nutritional decline
(estimate of effect 34 %). Weight loss was associated with adverse outcome and cachexia
may be an aetiological factor involved in the link between systemic inflammation and adverse
prognosis.
en
dc.description.abstract
CONCLUSIONS:
Systemic inflammation, weight loss, performance status, and stage of disease were the main
determinants of outcome in patients with gastro-oesophageal cancer. These factors were
used to devise a novel model to improve prognostic accuracy to aid clinical decision-making
for these patients. These studies identify systemic inflammation as both an important
prognostic indicator and a potential therapeutic target for patients with gastro-oesophageal
malignancy.
en
dc.identifier.uri
http://hdl.handle.net/1842/30162
dc.publisher
The University of Edinburgh
en
dc.relation.ispartof
Annexe Thesis Digitisation Project 2018 Block 19
en
dc.relation.isreferencedby
Already catalogued
en
dc.title
Aetiology of systemic inflammation and its link with prognosis in gastro-oesophageal cancer
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
MD Doctor of Medicine
en
This item appears in the following Collection(s)

